HemOnc Today New York

Healio.com brings you the highlights from HemOnc Today New York. Refer back to this page often to read the latest news, see perspectives and interviews with leading researchers and clinicians, and review archives of past meetings.

Meeting News

HemOnc Today New York to highlight advances in immunotherapy, targeted treatments

October 11, 2017
HemOnc Today is pleased to announce plans for a 3-day CME meeting designed to offer expert perspectives and practical insights into the use of…
Meeting NewsVideo

VIDEO: Key takeaways from HemOnc Today Melanoma and Cutaneous Malignancies

April 20, 2017
NEW YORK — Sanjiv S. Agarwala, MD, program director for HemOnc Today Melanoma and Cutaneous Malignancies, provided an overview of key takeaway…
Meeting NewsVideo

VIDEO: Speaker discusses targeted treatment for melanoma

April 19, 2017
NEW YORK — Jeffrey A. Sosman, MD, offered updates in the treatment of BRAF V600–mutant melanoma in light of greater use of immunotherapy…
Meeting NewsVideo

VIDEO: Speaker offers updates in cutaneous squamous cell carcinoma

April 16, 2017
NEW YORK — Axel Hauschild, MD, professor of dermatology and head of dermato-oncology at University Hospital in Kiel, Germany, provided an…
Meeting NewsVideo

VIDEO: Speaker reviews pros, cons of combining targeted therapy, immunotherapy for melanoma

April 15, 2017
NEW YORK — Jason J. Luke, MD, FACP, assistant professor of medicine at University of Chicago, spoke at HemOnc Today Melanoma and Cutaneous…
Meeting NewsVideo

VIDEO: Managing immune-related adverse events requires multidisciplinary approach

April 13, 2017
NEW YORK — Kathleen M. Madden, MSN, FNP, AOCNP, APHN, a nurse practitioner at the Laura and Isaac Perlmutter Cancer Center at the NYU Langone…
Meeting NewsVideo

VIDEO: Speaker offers updates on combinations, sequencing of immunotherapies for melanoma

April 12, 2017
NEW YORK — Michael A. Postow, MD, medical oncologist at Memorial Sloan Kettering Cancer Center, addressed the use of immune checkpoint…
Meeting NewsVideo

VIDEO: Speaker compares single-agent vs. combination immunotherapy for melanoma

April 9, 2017
NEW YORK — Mario Sznol, MD, professor of medicine at Yale Cancer Center, discusses whether single-agent or combination immunotherapy should be…
Meeting NewsVideo

VIDEO: Molecular alterations may identify intermediate stages of melanoma progression

April 8, 2017
NEW YORK — Boris C. Bastian, MD, PhD, director of the Clinical Cancer Genomics Laboratory at Hellen Diller Family Comprehensive Cancer Center…
Meeting NewsVideo

VIDEO: Gene mutation analysis an ‘important piece’ of melanoma diagnosis

April 3, 2017
NEW YORK — Klaus J. Busam, MD, director of the dermatopathology service at Memorial Sloan Kettering Cancer Center, highlighted the role of…

Meeting Calendar

HemOnc Today New York

March 8, 2018 - March 10, 2018

Advertisement
Advertisement